Morgan Stanley Call 44 HP 20.09.2.../ DE000ME4A9W2 /
26.06.2024 20:53:42 | Diff.+0.003 | Geld22:00:36 | Brief22:00:36 | Basiswert | Basispreis | Fälligkeit | Optionsart |
---|---|---|---|---|---|---|---|
0.061EUR | +5.17% | - Geld Vol: - |
- Brief Vol: - |
Helmerich and Payne ... | 44.00 - | 20.09.2024 | Call |
GlobeNewswire
23:44
CryptoHeap CEO Observes Bitcoin Trends Amid Market Volatility and U.S. Presidential Debate
GlobeNewswire
23:44
OkayCoin CEO Shares Expert Advice on How to Navigate Crypto Staking Successfully
GlobeNewswire
23:30
Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esoph...
GlobeNewswire
23:30
Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic e...
GlobeNewswire
23:00
CenterPoint Energy, Inc. to Host Webcast of Second Quarter 2024 Earnings Conference Call
GlobeNewswire
23:00
ROHM Develops a Novel VCSELED™ Infrared Light Source that Combines Features of VCSELs and LEDs
GlobeNewswire
22:53
OV Entertainment Group Acquires Brazilian Studio Kokku Games and Argentinian Studio 3OGS
GlobeNewswire
22:41
Transforming Cancer Care: Novotech Releases Report on Radiopharmaceuticals Global Clinical Trials La...
GlobeNewswire
22:39
NeOnc Technologies Completes $18.5 Million Financing, Advances Phase II Clinical Trials for Enhanced...
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite